Subsidiary12 Jun 2026, 08:31 pm
Dr. Lal PathLabs Incorporates Wholly Owned Subsidiary in Dubai
AI Summary
Dr. Lal PathLabs Ltd has announced the incorporation of its Wholly Owned Subsidiary (WOS) in Dubai, United Arab Emirates, named "DR LAL PATHLABS FZCO". The incorporation was completed on June 12, 2026, with the company receiving its Certificate of Incorporation from the Dubai Multi Commodities Centre (DMCC). The WOS aims to strategically invest in diagnostics and allied activities, including potential acquisitions, tie-ups, or joint ventures. Dr. Lal PathLabs has subscribed to the share capital of the new entity amounting to AED 1,91,35,000, acquiring 100% shareholding.
Key Highlights
- Dr. Lal PathLabs establishes a wholly-owned subsidiary in Dubai.
- The new entity, DR LAL PATHLABS FZCO, will focus on diagnostics investments.
- Initial investment of AED 1,91,35,000 made for 100% shareholding.
- Subsidiary aims to explore acquisitions, tie-ups, and joint ventures.
Price Impact
More from LALPATHLAB